Renaissance Technologies’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-55,416
| Closed | -$1.52M | – | 3646 |
|
|
2024
Q3 | $1.52M | Sell |
55,416
-33,188
| -37% | -$909K | ﹤0.01% | 2192 |
|
|
2024
Q2 | $2.29M | Sell |
88,604
-17,100
| -16% | -$443K | ﹤0.01% | 1801 |
|
|
2024
Q1 | $3.17M | Buy |
105,704
+56,398
| +114% | +$1.69M | 0.01% | 1734 |
|
|
2023
Q4 | $513K | Buy |
49,306
+14,090
| +40% | +$147K | ﹤0.01% | 2760 |
|
|
2023
Q3 | $481K | Buy |
35,216
+5,110
| +17% | +$69.8K | ﹤0.01% | 2718 |
|
|
2023
Q2 | $365K | Buy |
30,106
+5,518
| +22% | +$66.9K | ﹤0.01% | 3038 |
|
|
2023
Q1 | $313K | Sell |
24,588
-12,157
| -33% | -$155K | ﹤0.01% | 3094 |
|
|
2022
Q4 | $232K | Buy |
36,745
+11,442
| +45% | +$72.2K | ﹤0.01% | 3352 |
|
|
2022
Q3 | $571K | Sell |
25,303
-20,406
| -45% | -$460K | ﹤0.01% | 2851 |
|
|
2022
Q2 | $878K | Buy |
45,709
+30,755
| +206% | +$591K | ﹤0.01% | 2799 |
|
|
2022
Q1 | $694K | Buy |
14,954
+11,999
| +406% | +$557K | ﹤0.01% | 2977 |
|
|
2021
Q4 | $209K | Buy |
2,955
+1,436
| +95% | +$102K | ﹤0.01% | 3489 |
|
|
2021
Q3 | $177K | Buy |
+1,519
| New | +$177K | ﹤0.01% | 3229 |
|
|
2021
Q1 | – | Sell |
-13,388
| Closed | -$1.68M | – | 3393 |
|
|
2020
Q4 | $1.68M | Sell |
13,388
-9,281
| -41% | -$1.16M | ﹤0.01% | 2225 |
|
|
2020
Q3 | $2.47M | Buy |
22,669
+9,525
| +72% | +$1.04M | ﹤0.01% | 2003 |
|
|
2020
Q2 | $1.58M | Buy |
13,144
+2,535
| +24% | +$305K | ﹤0.01% | 2310 |
|
|
2020
Q1 | $1.07M | Buy |
+10,609
| New | +$1.07M | ﹤0.01% | 2393 |
|